Sean A. McCarthy

Dr. McCarthy joined CytomX in 2010 as Chief Business Officer and has served as Chief Executive Officer since 2011. Previously, Dr. McCarthy spent four years as a Transactional Partner at Pappas Ventures. Prior to Pappas, Sean drove a strategic reorganization of SGX Pharmaceuticals from a platform model to product-focused oncology company and served in multiple roles at Millennium Pharmaceuticals.

Dr. McCarthy is an author on multiple peer-reviewed scientific publications and issued patents and remains a member of the Board of Directors and Executive Committee of the California Life Sciences Association.

Dr. McCarthy received his Bachelor of Science degree in biochemistry and pharmacology at King’s College, University of London. He also received an MBA from the Rady School of Management at UCSD and a D. Phil. in cancer biology from St. John’s College, University of Oxford.